Chief Executive Officer
CurrentEmbold Therapeutics discovers and develops biologics for treatment of health conditions that occur later in life based. Its focus is on neurodegenerative diseases such as Parkinson’s and Alzheimer’s Disease. The company is built on its extensive experience in engineering therapeutic enzymes for a range of metabolic rare diseases.